-, -, PACLITAXEL , MK-2870, -, MK-1022, RAMUCIRUMAB , MK-2870, PARACETAMOL
MK-3475-06D
Phase 2 small_molecule active
Quick answer
-, -, PACLITAXEL , MK-2870, -, MK-1022, RAMUCIRUMAB , MK-2870, PARACETAMOL for Gastroesophageal cancer is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Gastroesophageal cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active